Correlation Between Recursion Pharmaceuticals and INGERSOLL

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and INGERSOLL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and INGERSOLL into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and INGERSOLL RAND LUXEMBOURG FIN, you can compare the effects of market volatilities on Recursion Pharmaceuticals and INGERSOLL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of INGERSOLL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and INGERSOLL.

Diversification Opportunities for Recursion Pharmaceuticals and INGERSOLL

-0.13

Correlation Coefficient

Recursion Pharmaceuticals  INGERSOLL

Good diversification

The 3 months correlation between Recursion and INGERSOLL is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and INGERSOLL RAND LUXEMBOURG FIN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INGERSOLL RAND LUXEM and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with INGERSOLL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INGERSOLL RAND LUXEM has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and INGERSOLL go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and INGERSOLL

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 2.39 times more return on investment than INGERSOLL. However, Recursion Pharmaceuticals is 2.39 times more volatile than INGERSOLL RAND LUXEMBOURG FIN. It trades about 0.03 of its potential returns per unit of risk. INGERSOLL RAND LUXEMBOURG FIN is currently generating about 0.01 per unit of risk. If you would invest  771.00  in Recursion Pharmaceuticals on September 20, 2024 and sell it today you would lose (59.00) from holding Recursion Pharmaceuticals or give up 7.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	27.88%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  INGERSOLL RAND LUXEMBOURG FIN

Recursion Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

INGERSOLL RAND LUXEM

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days INGERSOLL RAND LUXEMBOURG FIN has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for INGERSOLL RAND LUXEMBOURG FIN investors.

Pair Trading with Recursion Pharmaceuticals and INGERSOLL

The main advantage of trading using opposite Recursion Pharmaceuticals and INGERSOLL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, INGERSOLL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INGERSOLL will offset losses from the drop in INGERSOLL's long position.

The idea behind Recursion Pharmaceuticals and INGERSOLL RAND LUXEMBOURG FIN pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.